|
1
|
Whelan J, McTiernan A, Cooper N, Wong YK,
Francis M, Vernon S and Strauss SJ: Incidence and survival of
malignant bone sarcomas in England 1979–2007. Int J Cancer.
131:E508–E517. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ottaviani G and Jaffe N: The epidemiology
of osteosarcoma. Cancer Treat Res. 152:3–13. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Admassi D: Osteosarcoma of medial cuniform
bone. Ethiop Med J. 47:305–308. 2009.PubMed/NCBI
|
|
4
|
Heaton TE, Hammond WJ, Farber BA, Pallos
V, Meyers PA, Chou AJ, Price AP and LaQuaglia MP: A 20-year
retrospective analysis of CT-based pre-operative identification of
pulmonary metastases in patients with osteosarcoma: A single-center
review. J Pediatr Surg. 52:115–119. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Gelderblom H, Jinks RC, Sydes M, Bramwell
VH, van Glabbeke M, Grimer RJ, Hogendoorn PC, McTiernan A, Lewis
IJ, Nooij MA, et al: Survival after recurrent osteosarcoma: Data
from 3 European Osteosarcoma Intergroup (EOI) randomized controlled
trials. Eur J Cancer. 47:895–902. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Martin JW, Squire JA and Zielenska M: The
genetics of osteosarcoma. Sarcoma. 2012:6272542012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yang J and Zhang W: Newmolecular insights
into osteosarcoma targeted therapy. Curr Opin Oncol. 25:398–406.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Gubin DG, Weinert D, Rybina SV, Danilova
LA, Solovieva SV, Durov AM, Prokopiev NY and Ushakov PA: Activity,
sleep and ambient light have a different impact on circadian blood
pressure, heart rate and body temperature rhythms. Chronobiol Int.
34:632–649. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bueno C and Menna-Barreto L: Development
of sleep/wake, activity and temperature rhythms in newborns
maintained in a neonatal intensive care unit and the impact of
feeding schedules. Infant Behav Dev. 44:21–28. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kelleher FC, Rao A and Maguire A:
Circadian molecular clocks and cancer. Cancer Lett. 342:9–18. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Partch CL, Green CB and Takahashi JS:
Molecular architecture of the mammalian circadian clock. Trends
Cell Biol. 24:90–99. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Greene MW: Circadian rhythms and tumor
growth. Cancer Lett. 318:115–123. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kelly-Hayes M, Wolf PA, Kase CS, Brand FN,
McGuirk JM and D'Agostino RB: Temporal patterns of stroke onset.
The Framingham Study. Stroke. 26:1343–1347. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Muller JE, Stone PH, Turi ZG, Rutherford
JD, Czeisler CA, Parker C, Poole WK, Passamani E, Roberts R,
Robertson T, et al: Circadian variation in the frequency of onset
of acute myocardial infarction. N Engl J Med. 313:1315–1322. 1985.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hansen AB, Stayner L, Hansen J and
Andersen ZJ: Night shift work and incidence of diabetes in the
Danish Nurse Cohort. Occup Environ Med. 73:262–268. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Jensen LD, Cao Z, Nakamura M, Yang Y,
Bräutigam L, Andersson P, Zhang Y, Wahlberg E, Länne T, Hosaka K
and Cao Y: Opposing effects of circadian clock genes bmal1 and
period2 in regulation of VEGF-dependent angiogenesis in developing
zebrafish. Cell Rep. 2:231–241. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chen B, Tan Y, Liang Y, Li Y, Chen L, Wu
S, Xu W, Wang Y, Zhao W and Wu J: Per2 participates in AKT-mediated
drug resistance in A549/DDP lung adenocarcinoma cells. Oncol Lett.
13:423–428. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Storch KF, Lipan O, Leykin I, Viswanathan
N, Davis FC, Wong WH and Weitz CJ: Extensive and divergent
circadian gene expression in liver and heart. Nature. 417:78–83.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ripperger JA and Albrecht U: The circadian
clock component PERIOD2: From molecular to cerebral functions. Prog
Brain Res. 199:233–245. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chen ST, Choo KB, Hou MF, Yeh KT, Kuo SJ
and Chang JG: Deregulated expression of the PER1, PER2 and PER3
genes in breast cancers. Carcinogenesis. 26:1241–1246. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lin YM, Chang JH, Yeh KT, Yang MY, Liu TC,
Lin SF, Su WW and Chang JG: Disturbance of circadian gene
expression in hepatocellular carcinoma. Mol Carcinog. 47:925–933.
2008. View
Article : Google Scholar : PubMed/NCBI
|
|
22
|
Štorcelová M, Vicián M, Reis R, Zeman M
and Herichová I: Expression of cell cycle regulatory factors hus1,
gadd45a, rb1, cdkn2a and mre11a correlates with expression of clock
gene per2 in human colorectal carcinoma tissue. Mol Biol Rep.
40:6351–6361. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Relles D, Sendecki J, Chipitsyna G, Hyslop
T, Yeo CJ and Arafat HA: Circadian gene expression and
clinicopathologic correlates in pancreatic cancer. J Gastrointest
Surg. 17:443–450. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Neiva KG, Zhang Z, Miyazawa M, Warner KA,
Karl E and Nör JE: Cross talk initiated by endothelial cells
enhances migration and inhibits anoikis of squamous cell carcinoma
cells through STAT3/Akt/ERK signaling. Neoplasia. 11:583–593. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sgourakis G, Gockel I, Lyros O, Hansen T,
Mildenberger P and Lang H: Detection of lymph node metastases in
esophageal cancer. Expert Rev Anticancer Ther. 11:601–612. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Mazzoccoli G, Panza A, Valvano MR, Palumbo
O, Carella M, Pazienza V, Biscaglia G, Tavano F, Di Sebastiano P,
Andriulli A and Piepoli A: Clock gene expression levels and
relationship with clinical and pathological features in colorectal
cancer patients. Chronobiol Int. 28:841–851. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Gu X, Xing L, Shi G, Liu Z, Wang X, Qu Z,
Wu X, Dong Z, Gao X, Liu G, et al: The circadian mutation
PER2(S662G) is linked to cell cycle progression and tumorigenesis.
Cell Death Differ. 19:397–405. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Karantanos T, Theodoropoulos G, Pektasides
D and Gazouli M: Clock genes: Their role in colorectal cancer.
World J Gastroenterol. 20:1986–1992. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Miyazaki K, Wakabayashi M, Hara Y and
Ishida N: Tumor growth suppression in vivo by overexpression of the
circadian component, PER2. Genes Cells. 15:351–358. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Hua H, Wang Y, Wan C, Liu Y, Zhu B, Yang
C, Wang X, Wang Z, Cornelissen-Guillaume G and Halberg F: Circadian
gene mPer2 overexpression induces cancer cell apoptosis. Cancer
Sci. 97:589–596. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Fu L, Pelicano H, Liu JS, Huang P and Lee
CC: The circadian gene period2 plays an important role in tumor
suppression and DNA damage response in vivo. Cell. 111:41–50. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yang X, Wood PA, Oh EY, Du-Quiton J,
Ansell CM and Hrushesky WJ: Down regulation of circadian clock gene
Period 2 accelerates breast cancer growth by altering its daily
growth rhythm. Breast Cancer Res Treat. 117:423–431. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Koyanagi S, Kuramoto Y, Nakagawa H,
Aramaki H, Ohdo S, Soeda S and Shimeno H: A molecular mechanism
regulating circadian expression of vascular endothelial growth
factor in tumor cells. Cancer Res. 63:7277–7283. 2003.PubMed/NCBI
|
|
34
|
Elstrom RL, Bauer DE, Buzzai M, Karnauskas
R, Harris MH, Plas DR, Zhuang H, Cinalli RM, Alavi A, Rudin CM and
Thompso CB: Akt stimulates aerobic glycolysis in cancer cells.
Cancer Res. 64:3892–3899. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Yang X, He X, Yang Z and Jabbari E:
Mammalian PER2 regulates AKT activation and DNA damage response.
Biochem Cell Biol. 90:675–682. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Pérez-Yépez EA, Saldívar-Cerón HI,
Villamar-Cruz O, Pérez-Plasencia C and Arias-Romero LE: p21
activated kinase 1: Nuclear activity and its role during DNA damage
repair. DNA Repair (Amst). 65:42–46. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Williams GH and Stoeber K: The cell cycle
and cancer. J Pathol. 226:352–364. 2012. View Article : Google Scholar : PubMed/NCBI
|
